Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Tokunaga

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
ESMO Open|November 8, 2025
Association between adjuvant chemotherapy and outcomes in resected locoregional recurrence of hormone receptor-positive HER2-negative breast cancer: a multi-institutional retrospective studyY Ozaki, E Tokuda, Y Sagara, et al.
Breast Cancer Research and Treatment|March 25, 2017
Outcomes of fulvestrant therapy among japanese women with advanced breast cancer: a retrospective multicenter cohort study (JBCRG-C06; Safari)H Kawaguchi, N Masuda, T Nakayama, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 6, 2025
Pooled analysis of trastuzumab deruxtecan retreatment after recovery from grade 1 interstitial lung disease/pneumonitisH S Rugo, E Tokunaga, H Iwata, et al.
ESMO Open|August 10, 2023
Retrospective study to estimate the prevalence and describe the clinicopathological characteristics, treatments received, and outcomes of HER2-low breast cancerG Viale, M Basik, N Niikura, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 14, 2025
Imlunestrant with or without abemaciclib in advanced breast cancer: updated efficacy results from the phase III EMBER-3 trialK L Jhaveri, P Neven, M L Casalnuovo, et al.
ESMO Open|April 10, 2026
Patient-reported outcomes and qualitative interviews in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: results from the phase III EMBER-3 trialG Curigliano, J O'Shaughnessy, F-C Bidard, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
ESMO Open|November 8, 2025
Association between adjuvant chemotherapy and outcomes in resected locoregional recurrence of hormone receptor-positive HER2-negative breast cancer: a multi-institutional retrospective studyY Ozaki, E Tokuda, Y Sagara, et al.
Breast Cancer Research and Treatment|March 25, 2017
Outcomes of fulvestrant therapy among japanese women with advanced breast cancer: a retrospective multicenter cohort study (JBCRG-C06; Safari)H Kawaguchi, N Masuda, T Nakayama, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 6, 2025
Pooled analysis of trastuzumab deruxtecan retreatment after recovery from grade 1 interstitial lung disease/pneumonitisH S Rugo, E Tokunaga, H Iwata, et al.
ESMO Open|August 10, 2023
Retrospective study to estimate the prevalence and describe the clinicopathological characteristics, treatments received, and outcomes of HER2-low breast cancerG Viale, M Basik, N Niikura, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 14, 2025
Imlunestrant with or without abemaciclib in advanced breast cancer: updated efficacy results from the phase III EMBER-3 trialK L Jhaveri, P Neven, M L Casalnuovo, et al.
ESMO Open|April 10, 2026
Patient-reported outcomes and qualitative interviews in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: results from the phase III EMBER-3 trialG Curigliano, J O'Shaughnessy, F-C Bidard, et al.
Pageof 5